429 related articles for article (PubMed ID: 11238953)
1. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression.
Hutchinson J; Jin J; Cardiff RD; Woodgett JR; Muller WJ
Mol Cell Biol; 2001 Mar; 21(6):2203-12. PubMed ID: 11238953
[TBL] [Abstract][Full Text] [Related]
2. Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.
Webster MA; Hutchinson JN; Rauh MJ; Muthuswamy SK; Anton M; Tortorice CG; Cardiff RD; Graham FL; Hassell JA; Muller WJ
Mol Cell Biol; 1998 Apr; 18(4):2344-59. PubMed ID: 9528804
[TBL] [Abstract][Full Text] [Related]
3. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity.
Dijkers PF; Birkenkamp KU; Lam EW; Thomas NS; Lammers JW; Koenderman L; Coffer PJ
J Cell Biol; 2002 Feb; 156(3):531-42. PubMed ID: 11815629
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
[TBL] [Abstract][Full Text] [Related]
5. Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway.
Bailey JP; Nieport KM; Herbst MP; Srivastava S; Serra RA; Horseman ND
Mol Endocrinol; 2004 May; 18(5):1171-84. PubMed ID: 14963111
[TBL] [Abstract][Full Text] [Related]
6. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.
Hutchinson JN; Jin J; Cardiff RD; Woodgett JR; Muller WJ
Cancer Res; 2004 May; 64(9):3171-8. PubMed ID: 15126356
[TBL] [Abstract][Full Text] [Related]
7. Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells.
Mazumdar A; Kumar R
FEBS Lett; 2003 Jan; 535(1-3):6-10. PubMed ID: 12560069
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
Amundadottir LT; Leder P
Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
[TBL] [Abstract][Full Text] [Related]
9. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.
Shin DH; Jang SH; Kang BC; Kim HJ; Oh SH; Kong G
J Cell Physiol; 2011 May; 226(5):1340-52. PubMed ID: 20945346
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
Brunet A; Park J; Tran H; Hu LS; Hemmings BA; Greenberg ME
Mol Cell Biol; 2001 Feb; 21(3):952-65. PubMed ID: 11154281
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS
Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342
[TBL] [Abstract][Full Text] [Related]
12. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.
Qiao H; Saulnier R; Patryzkat A; Rahimi N; Raptis L; Rossiter J; Tremblay E; Elliott B
Cell Growth Differ; 2000 Feb; 11(2):123-33. PubMed ID: 10714768
[TBL] [Abstract][Full Text] [Related]
13. Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation.
Renner O; Blanco-Aparicio C; Grassow M; Cañamero M; Leal JF; Carnero A
Cancer Res; 2008 Dec; 68(23):9643-53. PubMed ID: 19047141
[TBL] [Abstract][Full Text] [Related]
14. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice.
White DE; Cardiff RD; Dedhar S; Muller WJ
Oncogene; 2001 Oct; 20(48):7064-72. PubMed ID: 11704830
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model.
Shukla S; Maclennan GT; Marengo SR; Resnick MI; Gupta S
Prostate; 2005 Aug; 64(3):224-39. PubMed ID: 15712212
[TBL] [Abstract][Full Text] [Related]
16. Transforming acidic coiled coil 1 promotes transformation and mammary tumorigenesis.
Cully M; Shiu J; Piekorz RP; Muller WJ; Done SJ; Mak TW
Cancer Res; 2005 Nov; 65(22):10363-70. PubMed ID: 16288026
[TBL] [Abstract][Full Text] [Related]
17. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
[TBL] [Abstract][Full Text] [Related]
18. Mammary gland involution is delayed by activated Akt in transgenic mice.
Schwertfeger KL; Richert MM; Anderson SM
Mol Endocrinol; 2001 Jun; 15(6):867-81. PubMed ID: 11376107
[TBL] [Abstract][Full Text] [Related]
19. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
20. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM
Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
